Why CVOTs Require a Different Approach: Optimizing Event Accrual to Reduce Trial Delays, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn why cardiovascular outcomes trials (CVOTs) require a different approach to enrollment, event accrual and study oversight. The featured speakers will discuss patient risk mix, event forecasting, blinded operational reporting and predictive analytics for identifying execution risks earlier. Attendees will also explore how integrated clinical and manufacturing execution can help reduce delays, improve trial performance and strengthen program value.
TORONTO, Oct. 7, 2026 /PRNewswire/ -- Cardiovascular outcomes trials (CVOTs) are among the most complex and resource-intensive studies in drug development, where operational execution can significantly affect timelines, capital efficiency and overall program value. This webinar examines why event-driven studies require a different operating model than traditional Phase III trials and how sponsors can optimize event accrual and trial performance to reduce execution risk, strengthen program value and support timely patient access to new therapies.
Unlike traditional studies with fixed completion timelines, CVOTs are driven by the accrual of major adverse cardiovascular events (MACE) and/or heart failure (CHF)-related events. Success depends not only on rapid enrollment but also on enrolling patients likely to experience qualifying events. Poor patient risk mix, slow event accrual, missed events and patient attrition can extend trial duration, increase costs and delay regulatory submission. This webinar will discuss how statistical engagement, enrollment strategies, event forecasting and recovery planning can improve study efficiency without compromising scientific rigor.
Drawing on new research from the Tufts Center for the Study of Drug Development (CSDD), the featured speakers will review how integrated clinical research and manufacturing execution can improve financial outcomes in large, event-driven Phase III programs. The analysis demonstrated gains in projected program value, shorter development timelines and strong returns on investment across both diabetes and cardiovascular development programs.
The webinar will also explore how operational blinded reporting, statistical monitoring and predictive analytics can optimize large, event-driven CVOTs by tracking patient risk mix, event accrual, retention, missed events, adjudication timelines and data completeness. The speakers will further explore evolving approaches such as cardiovascular event forecasting, eligibility analytics, AI-enabled adjudication and continuous operational feedback to identify risks, inform recovery strategies and improve execution predictability, while emphasizing the importance of experienced cardiovascular teams in maintaining scientific rigor and trial integrity.
Register for this webinar to learn how CVOT event forecasting, integrating clinical execution and data-driven operational strategies can reduce development timelines, strengthen asset value and improve trial performance.
Join experts from PPD clinical research business of Thermo Fisher Scientific, Paul Collins, Executive Director, Internal Medicine and Cardiovascular Lead; Peter G. Linde, MD, FASN, Vice President, Head Global Medical Officer, Biotech Solutions; Bill Dennis, Senior Director, Cardiovascular Outcomes & Strategy; and Rakhi Kilaru, MS, MBA, Executive Director, Statistical Science, for the live webinar on Friday, October 23, 2026, at 11am EDT (5pm CEST / EU-Central).
For more information, or to register for this event, visit Why CVOTs Require a Different Approach: Optimizing Event Accrual to Reduce Trial Delays.
ABOUT XTALKS
Xtalks – The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.
Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.
To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/
Contact:
Soumya Shashikumar
Tel: +1 (416) 977-6555 x371
Email: [email protected]
SOURCE Xtalks